Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty.
Recruiting · NCT06323018 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Tartu
View the official record on ClinicalTrials.gov →Interventions studied
Remote Ischemic PreconditioningSHAM
What this trial is about
Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.
Who can take part
Age range
65 Years to 90 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- age \>65 years
- undergoing total hip cemented hip arthroplasty
Exclusion criteria
- previously diagnosed peripheral artery disease on both upper limb
- RIPC is contraindicated
Where it is running
1 location listed.
- University of Tartu - Tartu, Tartu, Estonia